Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,048 across all filing types
Latest filing 2019-04-22 Major Shareholding Noti…
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
Becoming a substantial holder from MS 86 pages 1.9MB
Major Shareholding Notification Classification · 100% confidence The document text contains detailed information about substantial shareholdings, including the number of securities held, voting power, dates of acquisition, and nature of relevant interests. It lists multiple transactions and holdings by Morgan Stanley entities, indicating changes in significant share ownership levels. There is no indication of financial results, management commentary, or other report types. The content aligns with notifications of changes in major shareholdings, which is consistent with the category 'Major Shareholding Notification' (MRQ). The document length is substantial and contains detailed data, not just an announcement or a brief note, supporting classification as MRQ rather than a regulatory filing or announcement.
2019-04-22 English
France issues guidance requiring disinfection of probes 1
Regulatory Filings Classification · 95% confidence The document is a short announcement from Nanosonics Limited regarding new guidance issued by the French Ministry of Health on disinfection standards for ultrasound probes. It includes statements from the CEO about the impact of this guidance on their product and growth plans. There are no financial statements, regulatory filings, or detailed reports included. The document is under 5,000 characters and serves as a regulatory or market update rather than a formal report or filing. It does not fit categories like Annual Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit other specific categories.
2019-04-02 English
Appendix 3B 10 pages 136.2KB
Share Issue/Capital Change Classification · 100% confidence The document is a detailed announcement regarding the exercise of performance rights and the issue of shares under employee share plans. It includes an Appendix 3B, which is a standard form used in Australian securities markets to announce new issues of securities and apply for their quotation on the ASX. The document contains specific details about the number and class of securities issued, terms of the securities, compliance with the Corporations Act, and other regulatory disclosures related to the issuance of shares and options. There is no financial performance data, management discussion, or earnings information. The document is not a report but an official announcement of a capital change event (new share issue and securities issuance). Therefore, it fits the category of Share Issue/Capital Change (SHA).
2019-03-14 English
Change of Director's Interest Notice 3 pages 32.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and details the sale of shares by a company director, including specifics about the number of shares held before and after the transaction, the nature of the transaction (on-market sale), and compliance with the company's securities trading policy. It references listing rule 3.19A.2 and section 205G of the Corporations Act, which pertain to director shareholding disclosures. The content focuses exclusively on the director's personal share transactions and does not include financial statements, earnings data, or other report types. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is about 5,211 characters, sufficient to contain detailed transaction information rather than a brief announcement. Therefore, the correct classification is DIRS (Director's Dealing).
2019-03-03 English
Change of Director's Interest Notice 4 pages 73.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and details the sale of shares by Mr. Michael Kavanagh, a director and CEO, including the number of shares sold, the nature of the transaction, and the securities held before and after the sale. It references ASX listing rules and the Corporations Act, indicating it is a regulatory disclosure about insider trading or director share transactions. There is no financial performance data, earnings information, or report content. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives.
2019-02-25 English
Appendix 4D and Half Year Report 29 pages 2.0MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Nanosonics Limited Half Yearly Report' and references the reporting period ending 31 December 2018, with comparative data for 31 December 2017. It includes detailed financial statements such as the interim consolidated statement of profit or loss, statement of financial position, directors' report, auditor's independence declaration, and notes to the financial statements. The document explicitly states it is an interim report and complies with Australian Accounting Standard AASB 134 Interim Financial Reporting. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is a comprehensive interim financial report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2019
2019-02-24 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.